TAYLOR BEN R (Chief Financial Officer) reported 1 transaction at RECURSION PHARMACEUTICALS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 9/16/2026ACC: 0001601830-26-000110
Officer· Chief Financial Officer
Since Feb 2026
-5.40K
Net shares
Net seller
$18.4K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
5.40K disposed
Non-Derivative Transactions1
Class A Common Stock
Direct
Shares
−5.40K
Price / share
$3.41
Trade value
$18.40K
% of position
0.5%
9/15/2026
1.08M→1.07M
Total
Net shares
−5.40K
Net value
-$18.40K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 9/15/2026 | F · Tax Withholding | −5.40K | $3.41 | $18.40K | 0.5% | 1.08M | 1.07M |
| Total | −5.40K | -$18.40K | ||||||
Derivative Transactions0
No derivative transactions reported